The mRNA technology, which has proved so crucial to the vaccine breakthroughs, was, at the time, also considered too experimental by Dr Phil Dormitzer, Pfizer’s vice-president and chief scientific officer for viral vaccines.
Dr. Özlem Türeci
Browse the articles related to this topic below.
Join our community on Guilded.